This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Jan;11 Suppl 1(Suppl 1):S66-70.

doi: 10.1513/AnnalsATS.201308-285MG.

The lung microbiome. A new frontier in pulmonary medicine

James P Kiley¹, Elisabet V Caler

Affiliations

PMID: 24437410
PMCID: PMC5475396
DOI: 10.1513/AnnalsATS.201308-285MG

The lung microbiome. A new frontier in pulmonary medicine

James P Kiley et al. Ann Am Thorac Soc. 2014 Jan.

. 2014 Jan;11 Suppl 1(Suppl 1):S66-70.

doi: 10.1513/AnnalsATS.201308-285MG.

Authors

James P Kiley¹, Elisabet V Caler

Affiliation

¹ 1 National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 24437410
PMCID: PMC5475396
DOI: 10.1513/AnnalsATS.201308-285MG

No abstract available

PubMed Disclaimer

Figures

Figure 1. — Figure 1.
Selective pressures shaping the microbiome. Graphic representation of the interplay among environment, the microbiota of humans, the host genetics, and the immune system. Exposure to animals, foods, and siblings are the vehicle environmental bacteria use to access the human gut/lung axis. Disturbance in the balanced state by lack of exposure (extreme hygiene), inappropriate exposure (smoke), or viral infections may lead to disease. Adapted by permission from Reference .

See this image and copyright information in PMC

Similar articles

The lung microbiome. A new frontier in pulmonary medicine: introduction and perspective.
Martin RJ, Flores S, Kraft M. Martin RJ, et al. Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S1-2. doi: 10.1513/AnnalsATS.201308-255MG. Ann Am Thorac Soc. 2014. PMID: 24437397 No abstract available.
New developments in respiratory medicine: a primary immunodeficiency perspective.
Ng K, Hurst JR. Ng K, et al. Curr Opin Allergy Clin Immunol. 2020 Dec;20(6):549-556. doi: 10.1097/ACI.0000000000000690. Curr Opin Allergy Clin Immunol. 2020. PMID: 32941317 Review.
Rare pulmonary diseases: a path to the future.
Harari S, Agostini C. Harari S, et al. Respir Med. 2010 Jul;104 Suppl 1:S1. doi: 10.1016/j.rmed.2010.03.011. Epub 2010 Apr 28. Respir Med. 2010. PMID: 20427171 No abstract available.
[Urgent problems of rehabilitation of patients with lung diseases].
Kliachkin LM. Kliachkin LM. Klin Med (Mosk). 1990 Dec;68(12):105-6. Klin Med (Mosk). 1990. PMID: 2084326 Russian. No abstract available.
World Workshop on Oral Medicine VII: Targeting the microbiome for oral medicine specialists-Part 1. A methodological guide.
Varoni EM, Bavarian R, Robledo-Sierra J, Porat Ben-Amy D, Wade WG, Paster B, Kerr R, Peterson DE, Frandsen Lau E. Varoni EM, et al. Oral Dis. 2019 Jun;25 Suppl 1:12-27. doi: 10.1111/odi.13063. Oral Dis. 2019. PMID: 31140702 Review.

See all similar articles

Cited by

The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
Fastrès A, Felice F, Roels E, Moermans C, Corhay JL, Bureau F, Louis R, Clercx C, Guiot J. Fastrès A, et al. Int J Mol Sci. 2017 Dec 16;18(12):2735. doi: 10.3390/ijms18122735. Int J Mol Sci. 2017. PMID: 29258183 Free PMC article. Review.
Pulmonary arterial hypertension-associated changes in gut pathology and microbiota.
Sharma RK, Oliveira AC, Yang T, Kim S, Zubcevic J, Aquino V, Lobaton GO, Goel R, Richards EM, Raizada MK. Sharma RK, et al. ERJ Open Res. 2020 Jul 27;6(3):00253-2019. doi: 10.1183/23120541.00253-2019. eCollection 2020 Jul. ERJ Open Res. 2020. PMID: 32743008 Free PMC article.
Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study.
Man MA, Ungur RA, Motoc NS, Pop LA, Berindan-Neagoe I, Ruta VM. Man MA, et al. Diagnostics (Basel). 2023 Oct 9;13(19):3157. doi: 10.3390/diagnostics13193157. Diagnostics (Basel). 2023. PMID: 37835899 Free PMC article.
Mixed group of Rhizobiales microbes in lung and blood of a patient with fatal pulmonary illness.
Lo SC, Hung GC, Li B, Lei H, Li T, Nagamine K, Tsai S, Zucker MJ, Olesnicky L. Lo SC, et al. Int J Clin Exp Pathol. 2015 Nov 1;8(11):13834-52. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823697 Free PMC article.
Acute Radiation Syndrome and the Microbiome: Impact and Review.
Hollingsworth BA, Cassatt DR, DiCarlo AL, Rios CI, Satyamitra MM, Winters TA, Taliaferro LP. Hollingsworth BA, et al. Front Pharmacol. 2021 May 18;12:643283. doi: 10.3389/fphar.2021.643283. eCollection 2021. Front Pharmacol. 2021. PMID: 34084131 Free PMC article. Review.

See all "Cited by" articles

References

1. Daniel TM. The impact of tuberculosis on civilization. Infect Dis Clin North Am. 2004;18:157–165. - PubMed
1. Daniel TM. The origins and precolonial epidemiology of tuberculosis in the Americas: can we figure them out? Int J Tuberc Lung Dis. 2000;4:395–400. - PubMed
1. Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012;160:258–266. - PMC - PubMed
1. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med. 2013;187:1382–1387. - PMC - PubMed
1. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995;269:496–512. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov